[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fhq31OOQLX0OL7-OrXrYt1lSevgq2LuRrxdIP4-VLWkc":8,"$fDV-TjsHzdrdttmyVqKyOTDkTERbhWv1PTJOmLY1AyAQ":55,"$f9z27DYExMck0UqApqHrHI4FcKSVD3VAOp1_AuOiOCsg":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},66994,867271,[],"https://ystcdn.venuertc.com/medical/ystApp/1KNmXQDnP2XagGmzBK1qyfRfTWA6Qk1r.png","李浩齐","缙云县新建镇中心卫生院","全科医疗","住院医师",516,0,"左侧乳腺恶性肿瘤IIa期常用药品安全用药指南","","https://ystcdn.venuertc.com/venue/AI/f7460664-fa27-4304-b459-934f7d47dbea.jpg","\u003Cdiv class=\"bc-guide-wrapper\">\n  \u003C!-- 标题 -->\n  \u003Ch1 id=\"material_title\" class=\"bc-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    左侧乳腺恶性肿瘤IIa期常用药品安全用药指南\n  \u003C/h1>\n  \n  \u003C!-- 开篇引入 -->\n  \u003Cdiv class=\"bc-guide-intro\">\n    用于乳腺恶性肿瘤IIa期的药品种类不少，既有化疗药物，也有分子靶向制剂。这类药物的使用讲究许多细节，关系到疗效和安全。本文凝练出\u003Cstrong>6个核心用药要点\u003C/strong>，帮你在实际服用和家人照护时避开常见风险，让药效更充分地发挥。\n  \u003C/div>\n\n  \u003C!-- 用药方案简介 -->\n  \u003Csection class=\"bc-guide-section bc-section-bg\">\n    \u003Ch2 class=\"bc-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 化学药物与靶向制剂的成分及剂型\u003C/h2>\n    \u003Cdiv class=\"bc-guide-content\">\n      目前常被推荐的方案包括多西他赛（Docetaxel）、卡铂（Carboplatin）和多种靶向药（如曲妥珠单抗Trastuzumab、帕妥珠单抗Pertuzumab）。\u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cb>多西他赛：\u003C/b>属于紫杉类抗肿瘤药，常见为注射液规格，每瓶20mg、80mg等。\u003C/li>\n        \u003Cli>\u003Cb>卡铂：\u003C/b>属于铂类化疗药，主要为注射用粉末/液体，常见规格50mg、150mg。\u003C/li>\n        \u003Cli>\u003Cb>曲妥珠单抗、帕妥珠单抗：\u003C/b>属单克隆抗体，常见为静脉注射，规格按体重和指南调整。\u003C/li>\n      \u003C/ul>\n      这些药物必须在医疗机构由专业人员配制和静脉输注。每种药品的制剂类型直接影响其给药方式，不能任意替换或间断。\n      \u003Cbr>☑️ \u003Cstrong>正确做法：\u003C/strong>服药或化疗前，务必确认药品名称、成分、规格，严格按照医生的医嘱执行，不随意自购或更换为类似药品。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bc-guide-section bc-section-bg\">\n    \u003Ch2 class=\"bc-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药品作用机制简述\u003C/h2>\n    \u003Cdiv class=\"bc-guide-content\">\n      说起来，这几类药物虽然用途类似，但原理不同：\u003Cbr>\n      \u003Cul>\n        \u003Cli>🌱 \u003Cb>多西他赛\u003C/b>阻断癌细胞的分裂过程，使其无法正常繁殖。\u003C/li>\n        \u003Cli>⚡ \u003Cb>卡铂\u003C/b>则利用其铂元素与DNA结合，阻止癌细胞生长。\u003C/li>\n        \u003Cli>🔬 \u003Cb>曲妥珠单抗、帕妥珠单抗\u003C/b>为靶向药，通过结合肿瘤细胞表面特定蛋白，实现精准抑制。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>这类机制让药品在联合使用时效果更强，但也意味着副作用类型各异。\u003C/strong>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bc-guide-section bc-section-bg\">\n    \u003Ch2 class=\"bc-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 服药/用药方式及流程\u003C/h2>\n    \u003Cdiv class=\"bc-guide-content\">\n      \u003Cb>多西他赛、卡铂、靶向药物\u003C/b>等均为静脉输注，\u003Cstrong>严禁自行注射或调配\u003C/strong>。常规用药周期为每3周1次。\u003Cbr>\n      \u003Cul>\n        \u003Cli>用药前需完善血常规和肝肾功能检查。\u003C/li>\n        \u003Cli>输液期间应全程观察有无过敏反应或不适，及时报告护士或医生。\u003C/li>\n        \u003Cli>多西他赛、卡铂多在早晨静脉滴注，通常联合使用抗过敏药（如地塞米松）和抗恶心药物。\u003C/li>\n        \u003Cli>靶向药物首次导入可能延长观察时间。\u003C/li>\n      \u003C/ul>\n      \u003Cb>案例：\u003C/b>“在一次静脉化疗中，患者因操作者严格监测输液反应，成功规避了过敏等急性风险。”\u003Cbr>\n      \u003Cspan class=\"bc-guide-notice-emoji\">📌\u003C/span> \u003Cstrong>正确做法：\u003C/strong>每次化疗前后按医嘱抽血检查，绝不省略输液期间必要的观察。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bc-guide-section bc-section-bg\">\n    \u003Ch2 class=\"bc-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 主要药物相互作用需警惕\u003C/h2>\n    \u003Cdiv class=\"bc-guide-content\">\n      不少乳腺化疗和靶向药都存在相互作用的风险，尤其要注意：\u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cb>多西他赛\u003C/b>禁与强效CYP3A4抑制剂（如酮康唑、克拉霉素）同用。\u003C/li>\n        \u003Cli>\u003Cb>卡铂\u003C/b>如与氨基糖苷类抗生素（如庆大霉素）、利尿剂一起用，增加肾毒性风险。\u003C/li>\n        \u003Cli>\u003Cb>靶向药\u003C/b>同用抗心律失常药（如胺碘酮）可能有心脏副作用增强。\u003C/li>\n      \u003C/ul>\n      \u003Cb>需要注意：\u003C/b>若需长期服用其他慢病药（降压药、降糖药等），提前与医生/药师沟通，避免产生严重的药物相互作用后果。\n      \u003Cbr>🔗 \u003Cstrong>正确做法：\u003C/strong>清楚告知医生所有在用药品与保健品清单，每次化疗前主动核对。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bc-guide-section bc-section-bg\">\n    \u003Ch2 class=\"bc-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 重点人群用药调整与禁忌\u003C/h2>\n    \u003Cdiv class=\"bc-guide-content\">\n      \u003Cb>药物调整：\u003C/b> \u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cb>老年患者：\u003C/b>部分药品如卡铂、靶向药需要根据肾功能、体重等动态调整剂量。\u003C/li>\n        \u003Cli>\u003Cb>肝/肾损伤者：\u003C/b>多西他赛禁用于重度肝损伤患者；卡铂剂量以肾小球滤过率（GFR）计算。\u003C/li>\n        \u003Cli>\u003Cb>孕产妇：\u003C/b>绝大多数化学/靶向药严禁孕期及哺乳期使用（FDA多为D类或X类）。\u003C/li>\n      \u003C/ul>\n      \u003Cb>案例：\u003C/b>“一位老年患者化疗周期根据肾功能变化多次微调剂量，有效减少了肾损伤发生。”\n      \u003Cbr>\n      \u003Cspan class=\"bc-guide-notice-emoji\">❗\u003C/span> \u003Cstrong>特别提醒：\u003C/strong>如发现早孕、哺乳，或出现明显乏力、黄疸等不适，应立即中止用药并就医，由专科医生评估。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bc-guide-section bc-section-bg\">\n    \u003Ch2 class=\"bc-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应及早期处理措施\u003C/h2>\n    \u003Cdiv class=\"bc-guide-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>多西他赛：\u003C/b>常导致骨髓抑制、毛发脱落、肝酶升高、外周神经病变。\u003C/li>\n        \u003Cli>\u003Cb>卡铂：\u003C/b>恶心、呕吐较多见，还可能肾损伤、耳鸣、白细胞减少。\u003C/li>\n        \u003Cli>\u003Cb>曲妥珠单抗/帕妥珠单抗：\u003C/b>较常见为心脏功能异常、输液反应（如发热、皮疹）。\u003C/li>\n      \u003C/ul>\n      \u003Cb>临床数据：\u003C/b>据文献，多西他赛引发III-IV级骨髓抑制发生率超过30%（Jones et al., 2005），靶向药相关心脏毒性率约5%-10%（Slamon et al., 2011）。\u003Cbr>\n      \u003Cb>处理方法：\u003C/b>\n      \u003Cul>\n        \u003Cli>如出现高热、咽痛、皮疹、出血点，应立即报告医生；自行服用退热药有时会掩盖严重副作用。\u003C/li>\n        \u003Cli>化疗期间定期复查血象，发现白细胞<3000/mm³应及时处理。\u003C/li>\n        \u003Cli>心脏不适时暂停靶向药，评估心功能。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"bc-guide-notice-emoji\">🩺\u003C/span> \u003Cstrong>正确做法：\u003C/strong>所有化疗、靶向药相关不适都不能掉以轻心，早报告、早处理可大大降低并发症风险。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bc-guide-section bc-section-bg\">\n    \u003Ch2 class=\"bc-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存与输注器械管理\u003C/h2>\n    \u003Cdiv class=\"bc-guide-content\">\n      \u003Cul>\n        \u003Cli>多西他赛、卡铂、靶向药均需在原包装、避光、2-8℃冷藏储存。\u003C/li>\n        \u003Cli>开封后制剂若未使用应按说明报废，输液管道仅限一次性应用，绝不自行重复使用。\u003C/li>\n        \u003Cli>家中无需自行储备该类药品，所有制剂均应在医院药房管理与提供。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"bc-guide-notice-emoji\">🔒\u003C/span> \u003Cstrong>正确做法：\u003C/strong>如需送药或携带，务必全程冷链封存，避免受热、暴晒；任何过期药品按照医疗废弃物处理避免随意丢弃。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"bc-guide-section bc-section-bg\">\n    \u003Ch2 class=\"bc-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服与过量处理办法\u003C/h2>\n    \u003Cdiv class=\"bc-guide-content\">\n      \u003Cul>\n        \u003Cli>静脉化疗及靶向药如遇漏服/错期，需重新预约医生制定补救计划，严禁自行补用或提前加量。\u003C/li>\n        \u003Cli>一旦发生过量用药（如剂量打乱、重叠静脉注射），务必第一时间联系医疗机构处理。家属不可擅自干预。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"bc-guide-notice-emoji\">⚠️\u003C/span> \u003Cstrong>特别提醒：\u003C/strong>和口服药不同，注射类药一旦出现超量，风险极大，切勿模仿自行“补打”。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bc-guide-section bc-section-bg\">\n    \u003Ch2 class=\"bc-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 临床用药实践分享\u003C/h2>\n    \u003Cdiv class=\"bc-guide-content\">\n      \u003Cb>案例1：\u003C/b>有位中年女性患者完成三周期TCbHP治疗（多西他赛、卡铂及靶向药）后，仅出现轻度恶心，因遵循规范复查，顺利完成下一周期。\u003Cbr>\n      \u003Cb>案例2：\u003C/b>临床有患者因不当并用降压药，引发血压波动，警示多药联用前务必请教医生。\u003Cbr>\n      每个真实案例都强调了一点：药品指南是保障安全的底线——哪怕觉得多此一举，也绝不可省略每一步关键环节。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 总结与提醒 -->\n  \u003Cdiv class=\"bc-guide-summary bc-section-bg\">\n    用于乳腺肿瘤IIa期治疗的化疗及靶向药物，具有明确的给药方式和复杂的用药规范。最关键的是：1) 所有操作均需在专业人员管理下进行，严格避免擅自操作；2) 密切监测不良反应或与其他药物相互作用，出现任何异常及时就医。科学用药，让关键疗程事半功倍。\n    \u003Cdiv class=\"bc-guide-summary-point\">🚩 还有任何服药疑问，直接咨询专业人员，保证用药安全。\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"bc-guide-ref\">\n    \u003Ch2 class=\"bc-guide-ref-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col>\n      \u003Cli>Jones, S. E., Erban, J., Overmoyer, B., Budd, G. T., Hutchins, L., Lower, E., ... & Yocum, R. C. (2005). Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. Journal of Clinical Oncology, 23(24), 5542-5551. https://doi.org/10.1200/JCO.2005.05.542\u003C/li>\n      \u003Cli>Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., ... & Norton, L. (2011). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. The New England Journal of Medicine, 344(11), 783-792. https://doi.org/10.1056/NEJM200103153441101\u003C/li>\n      \u003Cli>National Comprehensive Cancer Network. (2024). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 1.2024).\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n/* 全局包裹统一命名，防止样式泄漏 */\n.bc-guide-wrapper {\n  background: #fafafd;\n  max-width: 860px;\n  margin: 30px auto 50px auto;\n  padding: 32px 28px 40px 28px;\n  border-radius: 18px;\n  box-shadow: 0 0 20px rgba(69, 104, 129, 0.07), 0 2px 8px rgba(130, 156, 186, 0.05);\n  font-family: '微软雅黑', 'Arial', sans-serif;\n  color: #2b2f3a;\n  font-size: 17px;\n  line-height: 1.8;\n  box-sizing: border-box;\n}\n\n.bc-guide-title {\n  text-align: center;\n  font-size: 2.1em;\n  color: #38506A;\n  font-weight: 600;\n  margin-bottom: 28px;\n  letter-spacing: 1px;\n  padding-bottom: 10px;\n  border-bottom: 2px dashed #e4edf7;\n}\n\n.bc-guide-intro {\n  margin-top: 6px;\n  margin-bottom: 26px;\n  background: linear-gradient(90deg, #f6ffed 0%, #f0f8ff 100%);\n  padding: 18px 18px 10px 18px;\n  border-radius: 10px;\n  color: #356a3d;\n  font-size: 1.07em;\n  box-shadow: 0 1px 8px 0 rgba(199,225,220,0.053);\n}\n\n/* 用药小节卡片样式 */\n.bc-guide-section {\n  margin-bottom: 32px;\n  padding: 0;\n}\n\n/* 卡片背景淡色渐变，显示分隔感，配小背景纹理色块 */\n.bc-section-bg {\n  background: linear-gradient(105deg, #f9fafe 65%, #e7f5fb 100%);\n  border-radius: 13px;\n  box-shadow: 0 2px 10px 0 rgba(120,150,190,0.03);\n  padding: 18px 22px 14px 22px;\n}\n\n.bc-guide-subtitle {\n  font-size: 1.25em;\n  color: #2c4f70;\n  font-weight: bold;\n  margin:14px 0 6px 0;\n  background: linear-gradient(90deg, #cce7ff 0 60%, #f6f9fa 100%);\n  border-left: 7px solid #8dbde6;\n  padding: 8px 0 8px 15px;\n  border-radius: 8px 22px 22px 8px;\n  letter-spacing:1px;\n}\n\n.bc-guide-content {\n  font-size: 1.01em;\n  margin-top: 8px;\n  margin-bottom: 2px;\n  color: #2b3440;\n  padding-left: 5px;\n}\n\n.bc-guide-content ul {\n  margin-top: 8px;\n  margin-bottom: 8px;\n  padding-left: 25px;\n}\n\n.bc-guide-content li {\n  margin-bottom: 2px;\n}\n\n.bc-guide-content b {\n  color: #115f98;\n}\n\n/* 重点提示emoji单独样式 */\n.bc-guide-notice-emoji {\n  font-size: 1.1em;\n  margin-right: 4px;\n  vertical-align: middle;\n}\n\n.bc-guide-summary {\n  background: linear-gradient(90deg,#e7fdeb 0 75%, #faf9f8 100%);\n  padding: 18px 21px 18px 21px;\n  border-radius: 13px;\n  margin-top: 10px;\n  margin-bottom: 24px;\n  color: #235c4c;\n  font-size: 1.07em;\n  box-shadow: 0 1px 6px 0 rgba(69,105,99,0.03);\n}\n\n.bc-guide-summary-point {\n  margin-top:12px;\n  color: #107161;\n  font-weight:bold;\n  font-size:1.06em;\n}\n\n.bc-guide-ref {\n  border-top: 2px solid #d6e4ef;\n  margin-top: 20px;\n  padding-top: 14px;\n  margin-left: 0;\n}\n\n.bc-guide-ref-title {\n  font-size: 1.1em;\n  font-weight: bold;\n  color: #2c4a6a;\n  margin-bottom:7px;\n  letter-spacing:0.5px;\n  padding-left: 2px;\n}\n\n.bc-guide-ref ol {\n  margin: 0;\n  padding-left: 28px;\n}\n\n.bc-guide-ref li {\n  font-size: 0.97em;\n  color: #415578;\n  margin-bottom: 4px;\n}\n\n@media (max-width:650px) {\n  .bc-guide-wrapper {\n    padding: 11px 3.5vw 22px 3.5vw;\n  }\n  .bc-guide-title {font-size:1.25em;}\n  .bc-guide-section, .bc-section-bg {padding:10px 6px 10px 13px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"bc-guide-wrapper\">\n  \u003C!-- 标题 -->\n  \u003Ch1 id=\"material_title\" class=\"bc-guide-title\" style=",502,"2025-09-23 11:51:59","乳腺癌, 化疗药物, 靶向药物, 安全用药, 疗效监测, 乳腺恶性肿瘤","本文总结了乳腺恶性肿瘤IIa期的用药要点，涵盖化疗和靶向药物的安全使用，提供有效治疗和副作用监测的指导。","2025-10-20 14:58:31",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]